Trial intelligence / Profile preview

Modified release metronidazole for pouchitis: pharmacokinetics vs immediate release

2009-015136-14Phase 2Completed

Sponsor
FORMAC Pharmaceuticals N.V.
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of metronidazole in pouchitis (3 arms), sponsored by FORMAC Pharmaceuticals N.V. Primary endpoint: Primary pharmacokinetic endpoint. Started Oct 2009; status: completed.

02

Drugs

metronidazole
03

Conditions

pouchitis

Beyond the preview

Go deeper on 2009-015136-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015136-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call